This inventor holds 24 USPTO granted patents and 9 published patent applications, plus 5 CIPO patents and 16 EPO patents, primarily in Factor XIa Inhibitors. Top assignees: Bristol-Myers Squibb Compnay, Bristol-Myers Squibb, Syngene International Limited. Active years: 2008-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Levittown, PA (US) (2008 - 2018)
- Newtown, PA (US) (2016 - 2023)
Company Filing History:
23 out of 3,742 
1 out of 39 
1 out of 7 
Years Active: 2008-2025
Areas of Expertise:
Title: The Innovative Contributions of Tianan Fang
Introduction
Tianan Fang, based in Newtown, PA, has made significant strides in the field of pharmaceutical sciences through his innovative inventions. With an impressive portfolio of 22 patents, Fang's work primarily focuses on selective LPA receptor inhibitors, showcasing his expertise and creativity in medicinal chemistry.
Latest Patents
Among his most recent patents, Fang has developed several notable compounds. One such invention is related to carbamoyloxymethyl triazole cyclohexyl acids, which are identified as LPA antagonists. This invention provides a unique formulation of compounds that can serve as selective inhibitors for LPA receptors. Another of his pioneering works involves cyclohexyl acid pyrazole azoles, also aimed at being LPA antagonists. This invention similarly details a formula for compounds that serve as selective LPA receptor inhibitors, further emphasizing Fang's commitment to enhancing therapeutic options in medicine.
Career Highlights
Tianan Fang's career includes impactful tenures at renowned companies like Bristol-Myers Squibb Company and Syngene International Limited. His experiences in these organizations highlight his capability in translating scientific knowledge into practical applications that advance the pharmaceutical industry.
Collaborations
Throughout his career, Fang has collaborated with esteemed colleagues including James R. Corte and Donald J. P. Pinto. These partnerships have not only enriched his professional journey but have also contributed to the broader scientific community, underscoring the importance of teamwork in driving innovations.
Conclusion
In conclusion, Tianan Fang's contributions to the field of pharmaceuticals through his extensive patent portfolio and innovative inventions are noteworthy. His work not only reflects his dedication as an inventor but also showcases the potential for significant advancements in therapeutic solutions. With a strong foundation and notable collaborations, Fang continues to be a leading figure in the development of novel medicinal compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile